moricizine has been researched along with Myocardial Infarction in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (45.95) | 18.7374 |
| 1990's | 20 (54.05) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aniukhovskiĭ, EP; Beloshapko, GG; Dremin, SA; Rozenshtraukh, LV | 4 |
| Dangman, KH; Hoffman, BF | 1 |
| Aniukhovskiĭ, EP; Rozenshtraukh, LV; Sekeresh, L; Vegkh, A | 1 |
| Gatsura, SV; Kaverina, NV; Turilova, AI | 1 |
| Grigor'eva, EK; Kaverina, NV; Lyskovtsev, VV; Senova, ZP | 1 |
| Merkulova, IN; Metelitsa, VI; Piotrovskiĭ, VK; Romina, NN | 1 |
| Bigger, JT; Fleiss, JL; Rolnitzky, LM; Steinman, RC | 1 |
| Anderson, JL; Carlson, M; Davies, R; Duff, HJ; Greene, HL; Hallstrom, AP; Huther, M; Kammerling, JM; Romhilt, DW | 1 |
| Aidonidis, I; Brachmann, J; Egel, E; Hilbel, T; Kuebler, W; Rizos, I | 1 |
| DeMaria, A; Gottlieb, S; Greene, HL; Hallstrom, A; Huther, M; Pratt, CM; Young, JB | 1 |
| Anderson, JL; Buckingham, TA; Carlson, MD; Carson, PE; Hallstrom, A; Henthorn, RW; Platia, EV | 1 |
| Anderson, JL; Capone, RJ; Cohen, JD; Epstein, AE; Hallstrom, AP; Liebson, PR; Rogers, WJ; Seals, AA; Wyse, DG | 1 |
| Brooks, MM; Gorkin, L; Kellen, J; Morris, M; Pawitan, Y; Schoenberger, JA; Schron, EB; Shumaker, S; Verter, J; Wiklund, I | 1 |
| Furuno, I; Mitamura, H; Ogawa, S; Okada, Y; Sadanaga, T; Tsutsumi, N; Yoshimoto, T | 1 |
| Brezsnyak, ML; Campion, J; Corum, J; Ettinger, A; Kellen, JC; McBride, R; Schron, E; Thomas, S; Todd, L | 1 |
| Tonkin, AM | 1 |
| Hashimoto, K; He, ZS; Komori, S; Tamura, K | 1 |
| Greene, HL; Henthorn, RW; Katz, RJ; Roden, DM; Salerno, DM; Woosley, RL | 1 |
| Akiyama, T; Barker, AH; Campbell, WB; Friedman, L; Josephson, RA; Keller, M; Papa, L; Pawitan, Y; Rubbert, P | 1 |
| Akiyama, T; Greenberg, H; Kuo, CS; Pawitan, Y; Reynolds-Haertle, RA | 1 |
| Kerin, NZ | 1 |
| Bigger, JT; Epstein, AE; Hallstrom, AP; Reynolds-Haertle, RA; Romhilt, DW; Wyse, DG | 1 |
| Cohen, JD; Hallstrom, A; Mahmarian, J; McBride, R; Steinberg, JS; Wyse, DG | 1 |
| Greene, HL; Hallstrom, AP; Huther, ML | 1 |
| Aniukhovskiĭ, EP; Beloshapko, GG; Blazhek, Z; Golovina, VA; Rozenshtraukh, LV; Vrana, M | 1 |
| Barker, AH; Capone, RJ; Echt, DS; Greene, HL; Hallstrom, AP; McBride, R; Richardson, DW; Roden, DM | 1 |
| Anderson, JL; Barker, AH; Fowles, RE; Griffith, LS; Hallstrom, AP; Ledingham, RB; Reiffel, JA; Young, JB; Yusuf, S | 1 |
| Camm, AJ; Garratt, C; Ward, DE | 1 |
| Aniukhovskiĭ, EP; Dremin, SA; Hageman, GR; Rozenshtraukh, LV; Urtaler, F | 1 |
| Dangman, KH; Danilo, P; le Marec, H; Rosen, MR | 1 |
1 review(s) available for moricizine and Myocardial Infarction
| Article | Year |
|---|---|
Treatment of ventricular arrhythmias after CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Ventricular Function, Left | 1992 |
19 trial(s) available for moricizine and Myocardial Infarction
| Article | Year |
|---|---|
Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Encainide; Female; Flecainide; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Risk Factors; Signal Processing, Computer-Assisted | 1994 |
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Failure; Humans; Moricizine; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Survival Analysis; Time Factors | 1995 |
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
Topics: Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Moricizine; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Stroke Volume; Survival Analysis | 1995 |
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Statistics as Topic; Survival Analysis | 1994 |
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Analysis; Ventricular Function, Left | 1993 |
Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1).
Topics: Arrhythmias, Cardiac; Chi-Square Distribution; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Prognosis; Psychological Tests; Psychology, Social; Regression Analysis; Social Support | 1993 |
The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
Topics: Aged; Anti-Arrhythmia Agents; Critical Care; Death, Sudden, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Myocardial Infarction; Nursing Assessment; Survival Rate; Ventricular Premature Complexes | 1996 |
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
Topics: Adult; Age Factors; Aged; Aging; Arrhythmias, Cardiac; Drug Therapy, Combination; Encainide; Flecainide; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Moricizine; Myocardial Infarction; Prognosis; Stroke Volume | 1992 |
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
Topics: Cardiac Complexes, Premature; Cause of Death; Drug Combinations; Electrocardiography; Encainide; Female; Flecainide; Follow-Up Studies; Heart Arrest; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Placebos; Risk Factors; United States | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Regression Analysis | 1991 |
Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Encainide; Feasibility Studies; Female; Flecainide; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Pilot Projects; Random Allocation; Stroke Volume; United States | 1988 |
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study).
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1989 |
Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Encainide; Flecainide; Humans; Imipramine; Moricizine; Multicenter Studies as Topic; Myocardial Infarction; Phenothiazines; Pilot Projects; Random Allocation; Statistics as Topic; Stroke Volume | 1989 |
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Encainide; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation | 1989 |
Lessons from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Phenothiazines; United States | 1989 |
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1988 |
17 other study(ies) available for moricizine and Myocardial Infarction
| Article | Year |
|---|---|
[Decrease in the fast sodium inflow current, a possible reason for the anti-arrhythmic action of etmozin and mexityl in the late stage of experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Female; Heart Ventricles; Ion Channels; Male; Mexiletine; Moricizine; Morpholines; Myocardial Infarction; Phenothiazines; Propylamines; Sodium; Tetrodotoxin; Time Factors | 1980 |
[Effect of tetrodotoxin and ethmozine on arrhythmias of a dog heart isolated in the late stage of experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Dogs; In Vitro Techniques; Moricizine; Morpholines; Myocardial Infarction; Phenothiazines; Tetrodotoxin | 1980 |
Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Depression, Chemical; Dogs; Heart Conduction System; In Vitro Techniques; Lidocaine; Moricizine; Myocardial Contraction; Myocardial Infarction; Phenothiazines; Purkinje Fibers; Synaptic Transmission | 1983 |
[Effect of etmozin and ethacizin (diethylamino analog of etmozin) on local microcardiac blood flow and the fibrillation threshold of the heart].
Topics: Animals; Anti-Arrhythmia Agents; Cats; Coronary Vessels; Dogs; Female; Male; Moricizine; Myocardial Infarction; Phenothiazines; Regional Blood Flow; Ventricular Fibrillation | 1984 |
[Characteristics of the protective action of ethacizin on the ischemic myocardium].
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Cell Membrane Permeability; Coronary Disease; Drug Evaluation, Preclinical; Energy Metabolism; Moricizine; Myocardial Infarction; Myocardium; Phenothiazines; Rabbits | 1984 |
[Ethacizin: pharmacologic properties and prospects for clinical application].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Heart Rate; Humans; Moricizine; Myocardial Infarction; Phenothiazines; Rabbits; Rats; Tachycardia | 1984 |
[Comparison of the intensity of the effect of ethmozine and its diethylamine analog on the ectopic foci of excitation at the late stage of experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Diethylamines; Dogs; Female; Heart Block; Heart Conduction System; Male; Moricizine; Morpholines; Myocardial Infarction; Phenothiazines; Time Factors | 1981 |
[Ethmozin pharmacokinetics after a single intravenous administration].
Topics: Adult; Aged; Drug Administration Schedule; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines | 1982 |
[Effect of the diethylamine analog of etmozin and cesium chloride on the idioventricular rhythm in dogs in the late stages of experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cesium; Chlorides; Dogs; Female; Male; Moricizine; Myocardial Infarction; Phenothiazines; Sinoatrial Node | 1981 |
Electrophysiological mechanisms of action of ethmozine that explain its antiarrhythmic efficacy in the late stage of experimental myocardial infarction in dogs.
Topics: Animals; Dogs; Heart Conduction System; Heart Ventricles; Moricizine; Myocardial Infarction; Tachycardia, Ventricular | 1994 |
Rate-dependent anisotropic conduction property in the epicardial border zone of canine myocardial infarcts and its modification by moricizine.
Topics: Analysis of Variance; Animals; Anisotropy; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Electric Stimulation; Female; Heart; Heart Conduction System; Injections, Intravenous; Male; Moricizine; Myocardial Infarction; Myocardium; Tachycardia, Ventricular | 1995 |
Inhibitory effect of moricizine on reperfusion induced tachyarrhythmias in rats--a comparison study with disopyramide and mexiletine.
Topics: Animals; Disopyramide; Heart; Hemodynamics; Male; Mexiletine; Moricizine; Myocardial Infarction; Rats; Rats, Inbred Strains; Reperfusion Injury; Tachycardia | 1992 |
Crime, misdemeanor, and arrhythmia decoding CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Risk Factors | 1991 |
The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Data Interpretation, Statistical; Double-Blind Method; Electrocardiography, Ambulatory; Flecainide; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic | 1991 |
[Effects of ethmozine on ventricular fibrillation threshold in acute occlusion of the coronary artery in dogs].
Topics: Animals; Dogs; Electric Stimulation; Female; Male; Moricizine; Myocardial Infarction; Time Factors; Ventricular Fibrillation | 1990 |
[Action of ethacizin on normal and anomalous forms of Purkinje fiber automaticity in the dog].
Topics: Animals; Anti-Arrhythmia Agents; Automatism; Barium; Coronary Disease; Dogs; Female; Heart Conduction System; Male; Membrane Potentials; Moricizine; Myocardial Infarction; Phenothiazines; Purkinje Fibers | 1986 |
An evaluation of automaticity and triggered activity in the canine heart one to four days after myocardial infarction.
Topics: Animals; Cardiac Pacing, Artificial; Dogs; Electrophysiology; In Vitro Techniques; Lidocaine; Moricizine; Myocardial Infarction; Phenothiazines; Tachycardia; Temperature | 1985 |